戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 treatment with the specific ADA inhibitor 2'-deoxycoformycin.
2 ndent on pharmacologic ablation of AAH by 2'-deoxycoformycin.
3 mycin is ribose, while it is deoxyribose for deoxycoformycin.
4 e, guanosine, and the picomolar inhibitor 2'-deoxycoformycin.
5  to malarial ADA complexes with adenosine or deoxycoformycin, 5'-methylthioribosyl groups are rotated
6                              Pentostatin (2'-deoxycoformycin), an inhibitor of adenosine deaminase, w
7        Combined treatment with adenosine and deoxycoformycin, an adenosine deaminase inhibitor, stimu
8 a 6-aminopurine source in the presence of 2'-deoxycoformycin, an inhibitor of adenine aminohydrolase
9  requirement for adenine or adenosine and 2'-deoxycoformycin, an inhibitor of parasite adenine aminoh
10 that exhibits an absolute requirement for 2'-deoxycoformycin, an inhibitor of the leishmanial adenine
11 ere performed to examine the binding of (8R)-deoxycoformycin and (8R)-coformycin to adenosine deamina
12 ns of mice treated with the ADA inhibitor 2'-deoxycoformycin (dCF) were elevated over 30-fold, sugges
13                                           2'-deoxycoformycin (DCF), a potent adenosine deaminase inhi
14 much greater potentiating effect than did 2'-deoxycoformycin (DCF), although DCF is a more potent ADA
15       The nucleoside analogs fludarabine, 2'-deoxycoformycin (DCF), and 2-chlorodeoxyadenosine (CdA),
16 , 2-chlorodeoxyadenosine (2CDA; P = .37), or deoxycoformycin (DCF; P = .7).
17 s treated with the specific ADA inhibitor 2'-deoxycoformycin exhibited features of the human disease,
18 axprt triple knock-out no longer required 2'-deoxycoformycin for growth and was avirulent in mice wit
19 n cannot proliferate indefinitely without 2'-deoxycoformycin or with hypoxanthine, guanine, xanthine,
20 es approximately 10(-13) M) (8R)-hydroxyl-2'-deoxycoformycin (pentostatin), a transition state analog
21  to determine the potential usefulness of 2'-deoxycoformycin (pentostatin), an inhibitor of adenosine
22 nosine and the adenosine deaminase inhibitor deoxycoformycin potentiated NT-induced Isc increase.
23 nding of transition-state analogue inhibitor deoxycoformycin to the enzyme.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。